FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198172914> ?p ?o ?g. }

• W3198172914 endingPage "1357" @default.
• W3198172914 startingPage "1357" @default.
• W3198172914 abstract "Stroke is one of the major causes of disability and the second major cause of death around the globe. There is a dire need for an ultrasensitive detection tool and an effective and efficient therapeutic system for both detection and treatment of stroke at its infancy stage. Carbon nanotubes are promising nanomaterials for tackling these challenges. The loading of dexamethasone and decoration of PEGylated multiwalled carbon nanotube with atrial natriuretic peptide (ANP) antibody and fluorescein isothiocyanate for targeting ischemic site in the rat stroke model is presented here. Functionalisation of carbon nanotubes with dexamethasone (DEX), polyethylene glycol (PEG), fluorescein isothiocyanate (FITC), and ANP antibody caused a 63-fold increase in the D band intensity as illustrated by Raman. The characteristic band intensity increase was observed at 1636 nm following functionalisation of carbon nanotubes with polyethylene glycol and dexamethasone as confirmed by Fourier Transform Infrared. These findings have demonstrated the coupling capability of atrial natriuretic peptide antibody to DEX-PEG-CNTs. The baseline plasma atrial natriuretic peptide levels were ranging from 118 to 135.70 pg/mL prior to surgery and from 522.09 to 552.37 following common carotid artery occlusion. A decrease in atrial natriuretic peptide levels to 307.77 was observed when the rats were treated with FITC-DEX-PEG-ANP-CNTs, PEG-CNTs and DEX with a significant drop in the FITC-DEX-PEG-ANP-CNTs treated group. Fluorescence was detected in FITC-DEX-PEG-CNTs and FITC-DEX-PEG-ANP-CNTs treated ischemic stroke rats. The highest fluorescence intensity was reported in plasma (2179) followed by the kidney (1563) and liver (1507). These findings suggest a beneficial role that is played by the FITC-DEX-PEG-ANP-CNTs in the reduction of inflammation in the ischemic stroke induced rats that could induce a successful treatment of ischemic stroke." @default.
• W3198172914 created "2021-09-13" @default.
• W3198172914 creator A5003185613 @default.
• W3198172914 creator A5076703528 @default.
• W3198172914 creator A5086748081 @default.
• W3198172914 date "2021-08-28" @default.
• W3198172914 modified "2023-09-26" @default.
• W3198172914 title "Atrial Natriuretic Peptide Antibody-Functionalised, PEGylated Multiwalled Carbon Nanotubes for Targeted Ischemic Stroke Intervention" @default.
• W3198172914 cites W1486131515 @default.
• W3198172914 cites W1970349598 @default.
• W3198172914 cites W1970688266 @default.
• W3198172914 cites W2011738304 @default.
• W3198172914 cites W2015747338 @default.
• W3198172914 cites W2018858346 @default.
• W3198172914 cites W2053230173 @default.
• W3198172914 cites W2071040908 @default.
• W3198172914 cites W2101673712 @default.
• W3198172914 cites W2111318497 @default.
• W3198172914 cites W2127972294 @default.
• W3198172914 cites W2162661261 @default.
• W3198172914 cites W2262478976 @default.
• W3198172914 cites W2406348223 @default.
• W3198172914 cites W2553476368 @default.
• W3198172914 cites W2568903760 @default.
• W3198172914 cites W2591893859 @default.
• W3198172914 cites W2605361667 @default.
• W3198172914 cites W2796785666 @default.
• W3198172914 cites W2804159310 @default.
• W3198172914 cites W2807664483 @default.
• W3198172914 cites W2884896214 @default.
• W3198172914 cites W2890154843 @default.
• W3198172914 cites W2898012966 @default.
• W3198172914 cites W2899346549 @default.
• W3198172914 cites W2904328215 @default.
• W3198172914 cites W2912846155 @default.
• W3198172914 cites W2945964100 @default.
• W3198172914 cites W2956057877 @default.
• W3198172914 cites W3001632525 @default.
• W3198172914 cites W3004429638 @default.
• W3198172914 cites W3005979627 @default.
• W3198172914 cites W3006939146 @default.
• W3198172914 cites W3009164764 @default.
• W3198172914 cites W3011058644 @default.
• W3198172914 cites W3013758203 @default.
• W3198172914 cites W3014041745 @default.
• W3198172914 cites W3023327099 @default.
• W3198172914 cites W3035222407 @default.
• W3198172914 cites W3035863374 @default.
• W3198172914 cites W3047369524 @default.
• W3198172914 cites W3080311571 @default.
• W3198172914 cites W3087396862 @default.
• W3198172914 cites W3089565219 @default.
• W3198172914 cites W3092767102 @default.
• W3198172914 cites W3133682644 @default.
• W3198172914 doi "https://doi.org/10.3390/pharmaceutics13091357" @default.
• W3198172914 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8471373" @default.
• W3198172914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34575433" @default.
• W3198172914 hasPublicationYear "2021" @default.
• W3198172914 type Work @default.
• W3198172914 sameAs 3198172914 @default.
• W3198172914 citedByCount "3" @default.
• W3198172914 countsByYear W31981729142022 @default.
• W3198172914 countsByYear W31981729142023 @default.
• W3198172914 crossrefType "journal-article" @default.
• W3198172914 hasAuthorship W3198172914A5003185613 @default.
• W3198172914 hasAuthorship W3198172914A5076703528 @default.
• W3198172914 hasAuthorship W3198172914A5086748081 @default.
• W3198172914 hasBestOaLocation W31981729141 @default.
• W3198172914 hasConcept C10138342 @default.
• W3198172914 hasConcept C121332964 @default.
• W3198172914 hasConcept C126322002 @default.
• W3198172914 hasConcept C162324750 @default.
• W3198172914 hasConcept C185592680 @default.
• W3198172914 hasConcept C2775846464 @default.
• W3198172914 hasConcept C2775915353 @default.
• W3198172914 hasConcept C2776964284 @default.
• W3198172914 hasConcept C2777019933 @default.
• W3198172914 hasConcept C2778069365 @default.
• W3198172914 hasConcept C2778198053 @default.
• W3198172914 hasConcept C2780401358 @default.
• W3198172914 hasConcept C54400483 @default.
• W3198172914 hasConcept C55493867 @default.
• W3198172914 hasConcept C62520636 @default.
• W3198172914 hasConcept C71924100 @default.
• W3198172914 hasConcept C91881484 @default.
• W3198172914 hasConceptScore W3198172914C10138342 @default.
• W3198172914 hasConceptScore W3198172914C121332964 @default.
• W3198172914 hasConceptScore W3198172914C126322002 @default.
• W3198172914 hasConceptScore W3198172914C162324750 @default.
• W3198172914 hasConceptScore W3198172914C185592680 @default.
• W3198172914 hasConceptScore W3198172914C2775846464 @default.
• W3198172914 hasConceptScore W3198172914C2775915353 @default.
• W3198172914 hasConceptScore W3198172914C2776964284 @default.
• W3198172914 hasConceptScore W3198172914C2777019933 @default.
• W3198172914 hasConceptScore W3198172914C2778069365 @default.
• W3198172914 hasConceptScore W3198172914C2778198053 @default.
• W3198172914 hasConceptScore W3198172914C2780401358 @default.
• W3198172914 hasConceptScore W3198172914C54400483 @default.

• next